Marie Bosslett, Assistant Editor

The multicenter trial reported high response rates and low risk of discontinuation for treating long-term chronic inducible urticaria.

With this combined administration, patients saw noticeable and lasting improvements in severe cases of AD.

Results from Society for Melanoma Research Congress demonstrated excellent predictive power of noninvasive CP-GEP Merlin test.

Although further research is still needed, dermatologists and patients are generally satisfied with teledermatology treatment.

This new indication adds to existing clearance of a non-drug treatment for mild to severe inflammatory acne vulgaris.

ALPHA compared alitretinoin and phototherapy for speed and efficacy when treating chronic hand eczema.

Investigators noted that further research is needed to monitor the prevalence of cardiovascular disease in patients with vitiligo.

The novel drug demonstrated tolerability for AK treatment when applied to a field of 100 cm2 of the face or scalp.

The IL-17 inhibitor demonstrated biologic-level efficacy in moderate to severe plaque psoriasis.